Immune response with sipuleucel-T in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Phase II ProACT study

被引：0
|
作者：
Gardner, Thomas A.
Petrylak, Daniel Peter
Corman, John M.
Hall, Simon
Weinstein, Ralph
Keyser, Robert
Sims, Robert Brownell
Sanders, Amanda
Sheikh, Nadeem A.
Higano, Celestia S.
机构：
[1] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA
[2] Columbia Univ, Med Ctr, New York, NY USA
[3] Virginia Mason Med Ctr, Seattle, WA 98101 USA
[4] Mt Sinai Sch Med, New York, NY USA
[5] US Oncol, Portland, OR USA
[6] Dendreon Corp, Seattle, WA USA
[7] Univ Washington, Sch Med, Seattle, WA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 06期
关键词：
D O I：
10.1200/jco.2013.31.6_suppl.148
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
148
引用
收藏
页数：1
相关论文
共 50 条
  • [21] TREATMENT PRACTICE PATTERNS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PATIENTS PRIOR TO RECEIVING SIPULEUCEL-T: DATA FROM PROCEED
    Cooperberg, Matthew
    Sartor, Oliver
    Pieczonka, Christopher
    Concepcion, Raoul
    Kassabian, Vahan
    Tutrone, Ronald
    Bailen, James
    Shore, Neal
    Karsh, Lawrence
    Hertzman, Bernard
    Penson, David
    Mccoy, Candice
    Sandler, Andrew
    Whitmore, James
    Tyler, Robert
    Higano, Celestia
    JOURNAL OF UROLOGY, 2013, 189 (04): : E399 - E400
  • [22] Pilot trial of sipuleucel-T, with or without pTVG-HP DNA vaccine, in patients with metastatic, castration-resistant prostate cancer (mCRPC)
    Wargowski, Ellen
    Johnson, Laura
    Liu, Glenn
    Eickhoff, Jens
    Staab, Mary Jane
    McNeel, Douglas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [23] Interdisciplinary Critique of Sipuleucel-T as Immunotherapy in Castration-Resistant Prostate Cancer
    Huber, Marie L.
    Haynes, Laura
    Parker, Chris
    Iversen, Peter
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (04) : 273 - 279
  • [24] Analysis of Circulating Immune Biomarkers by Race in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Sipuleucel-T
    Hawley, Jessica E.
    Pan, Samuel
    Kandadi, Harini
    Chaimowitz, Matthew G.
    Sheikh, Nadeem
    Drake, Charles G.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (02): : 314 - 317
  • [25] Economic evaluation of sipuleucel-T immunotherapy in castration-resistant prostate cancer
    Holko, Przemyslaw
    Kawalec, Pawel
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (01) : 63 - 73
  • [26] CHARACTERIZATION OF LONG-TERM SURVIVORS FROM PROCEED, A REGISTRY OF SIPULEUCEL-T IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC)
    Karsh, Lawrence I.
    Armstrong, Andrew J.
    Pieczonka, Christopher
    Dakhil, Shaker
    Vacirca, Jeffrey
    Vogelzang, Nicholas J.
    Concepcion, Raoul S.
    Bailen, James
    Mantz, Constantine
    Tutrone, Ronald F.
    Chang, Nancy N.
    Brown, Bruce
    Scholz, Mark C.
    JOURNAL OF UROLOGY, 2019, 201 (04): : E470 - E471
  • [27] Re: Interdisciplinary Critique of Sipuleucel-T as Immunotherapy in Castration-Resistant Prostate Cancer Response
    Huber, Marie L.
    Haynes, Laura
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (18) : 1422 - 1423
  • [28] OPTIMAL TIMING FOR TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC): SEQUENCING AND IDENTIFYING PARAMETERS OF EARLY PROGRESSION WITH SIPULEUCEL-T
    Crawford, E. David
    Kibel, Adam
    Shore, Neal
    JOURNAL OF UROLOGY, 2013, 189 (04): : E393 - E394
  • [29] Real-world PROCEED registry data: Sipuleucel-T in elderly men with metastatic castration-resistant prostate cancer (mCRPC).
    Armstrong, Andrew J.
    Olsson, Carl A.
    Schnadig, Ian D.
    Concepcion, Raoul S.
    Vacirca, Jeffrey L.
    Tutrone, Ronald F.
    Dakhil, Shaker R.
    Chang, Nancy N.
    Tang, Hong
    Brown, Bruce
    Vogelzang, Nicholas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [30] COST-EFFECTIVENESS ANALYSIS OF ABIRATERONE AND SIPULEUCEL-T IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    Gong, C. L.
    Hay, J. W.
    VALUE IN HEALTH, 2014, 17 (03) : A82 - A83
12345